| Identification |
| Name: | 3-Pyridinecarboxylicacid,6-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl]- |
| Synonyms: | AGN 192620;ALRT 268; CD 3127; LG 100268; LG 268; LGD 100268; LGD 1268 |
| CAS: | 153559-76-3 |
| Molecular Formula: | C24H29 N O2 |
| Molecular Weight: | 363.49 |
| InChI: | InChI=1/C24H29NO2/c1-15-12-18-19(23(4,5)9-8-22(18,2)3)13-17(15)24(10-11-24)20-7-6-16(14-25-20)21(26)27/h6-7,12-14H,8-11H2,1-5H3,(H,26,27) |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 248.3°C |
| Boiling Point: | 487°Cat760mmHg |
| Density: | 1.115g/cm3 |
| Refractive index: | 1.577 |
| Flash Point: | 248.3°C |
| Usage: | A potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM) |
| Safety Data |
| |
 |
